APOE ε4 carriers” />

Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Neurology | Nursing | Pathology | Journal

Back to Journal Articles

APOE Status, Exercise Combo Impact Amyloid Deposition

Last Updated: January 12, 2012.

 

Sedentary lifestyle associated with increased amyloid deposits in APOE ε4 carriers

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
For cognitively normal carriers of APOE ε4, a sedentary lifestyle is associated with an increased risk of amyloid deposition, according to a study published online Jan. 9 in the Archives of Neurology.

THURSDAY, Jan. 12 (HealthDay News) -- For cognitively normal carriers of APOE ε4, a sedentary lifestyle is associated with an increased risk of amyloid deposition, according to a study published online Jan. 9 in the Archives of Neurology.

Denise Head, Ph.D., from Washington University in St. Louis, and colleagues investigated whether physical activity moderates the correlation between APOE genotype and amyloid deposition in 201 cognitively normal adults (aged 45 to 88 years). APOE ε4 genotyping data were collected, and exercise levels were determined via a questionnaire. Cerebrospinal fluid (CSF) samples were collected from 165 participants, and 163 individuals underwent amyloid imaging with carbon 11-labeled Pittsburgh Compound B ([11C]PiB).

The researchers found that, compared with noncarriers, APOE ε4 carriers had evidence of significantly higher [11C]PiB binding and significantly lower levels of Aβ42 in the CSF. An interaction between APOE status and exercise engagement was seen with [11C]PiB binding; a more sedentary lifestyle was associated with significantly increased [11C]PiB binding for APOE ε4 carriers, but not noncarriers (P = 0.013 and 0.20, respectively). The associations remained significant after adjusting for confounding variables.

"These results suggest that cognitively normal sedentary APOE ε4-positive individuals may be at augmented risk for cerebral amyloid deposition," the authors write.

Two of the authors disclosed financial relationships with pharmaceutical, biotechnology, and medical device companies.

Abstract
Full Text

Copyright © 2012 HealthDay. All rights reserved.


Previous: Parabens Seen in Almost All Breast Mastectomy Samples Next: Three Embryos Should Never Be Implanted in IVF

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.